The SITC Sparkathon is an exciting opportunity for early career professionals interested in solving hurdles facing the cancer immunotherapy field. Ignite innovation – apply to participate in the SITC Sparkathon today!
SITC connectED is the new adaptive learning portal connecting users to online educational activities about cancer immunotherapy with opportunities for continuing education credits.
Visit the SITC 2017 Annual Meeting website for the latest information on the premier destination for scientific exchange, education and networking in the cancer immunotherapy field.
Non-Small Cell Lung Cancer Immunotherapy: Clinical Management
Complete this FREE online CME/CNE activity to learn more about immunotherapy for non-small cell lung cancer, then engage your patients in discussion today!
*Current as of August 2016
Learn basic immunology principles, the mechanisms and clinical applications of immunotherapy for disease states with FDA-approved treatments and so much more. Join us June 29 in Los Angeles for our Advances in Cancer Immunotherapy™ program, SITC's regional cancer immunotherapy education series.
Learn and share information in the new SITC Cancer Immunotherapy CONNECT Open Forum! Follow a few easy steps to create a free SITC CONNECT account, upload a profile photo and join the conversation.
This course will review tumor immunology as the foundation of cancer immunotherapy, emphasizing fundamental principles, recent clinical advances, current limitations and opportunities for furthering clinical progress.
Explore resources and educational opportunities for cancer
patients and those who advocate for them.
Track the latest advancements and educational opportunities in
cancer immunotherapy and immunology.
Advance science, submit your
manuscript and monitor the global progress of cancer immunotherapy research.
FDA approves first cancer treatment for any solid tumor with a specific genetic feature Do you know any commercially available kit for testing microsatellite instability in this (immunotherapy) context please? ------------------------------ Stergios ...
Don't miss Oncology Central 's FREE CME-accredited symposium on immuno-oncology. This virtual event features speakers such as James Gulley from the National Cancer Institute and Susan Slovins from Memorial Sloan Kettering Cancer Center.
Talks include ...
Did you know that through SITC Cancer Immunotherapy CONNECT you have the opportunity to ask questions of peers and colleagues from across the world?
Discuss the latest advancement in cancer immunotherapy, receive feedback on your line of work, ...
Donate today to support early career scientists who are emerging leaders seeking to advance research in the cancer immunotherapy field.
An open access, peer-reviewed journal, the Journal for ImmunoTherapy of Cancer (JITC) is the global voice of the society, producing original research articles, literature reviews and more on tumor immunology and cancer immunotherapy.
It is the mission of the Society for Immunotherapy of Cancer to improve cancer patient outcomes by advancing the science, development and application of cancer immunology and immunotherapy through our core values of interaction/integration, innovation, translation and leadership in the field. SITC aims to make cancer immunotherapy a standard of care and the word “cure” a reality for cancer patients everywhere.
Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: firstname.lastname@example.org